PRs are one of the most cost effective marketing tools online! Signup Today!

Blog

PRESS RELEASE: Church Militant Attacked by Leftists

Posted by on 3:57 am in Press Release | 0 comments

FERNDALE, Mich. (ChurchMilitant.com) – Church Militant, a 12-year-old Catholic media apostolate, with headquarters in the Detroit suburb of Ferndale, is coming under attack by Antifa-related protestors claiming the religious organization inspires a “culture of rape” and is “white supremacist.”

The group Michigan Peoples Defense Network (MPDN) is planning a demonstration at Church Militant’s third annual Strength and Honor Conference, to be held in Sterling Heights, Michigan on Saturday, August 5. The conference is entirely theological in nature, offering talks on the essential role of sacrificial masculinity required of Catholic men to be good husbands and fathers. MPDN’s aim is to shut down the event.

In a further effort to intimidate, MPDN is holding a press conference on the sidewalk in front Church Militant studios Friday, July 28, right by the front door, announcing the August 5 protest.

The claims by MPDN are completely false and unfounded. The claim that Church Militant is a promoter of white male supremacy is immediately contradicted by the following facts:

  • Church Militant has legal immigrants (including first-generation immigrants) employed in key roles. 
  • Half the organization’s departments are headed by women (one who is a legal immigrant)

Additionally, the claim that the conference is about “men’s rights” is a deliberate distortion. The conference is about men’s obligations, not “rights.”

Church Militant absolutely condemns and abhors the lies and violence that have become the hallmark of the Antifa movement, which MPDN members associate with on social media. Church Militant is not a hate group; MPDN is the real hate group, trying to intimidate religious organizations into silence and shut down a conference meant to help men become better husbands, fathers, sons and brothers by fostering the virtues of humility, charity and sacrifice.

Church Militant is further disturbed by the group’s thinly veiled threats of physical violence present in the language of their site and Facebook page. This kind of discourse cannot be allowed to stand in a civilized nation.

Church Militant is open to discussion with anyone, and have indeed made this a hallmark of the work conducted here for a dozen years, but we will not be cowed by lies and thug tactics becoming so commonplace on the Left.

The real bone of contention that MPDN has with Church Militant is not the spurious claims and lies it’s telling, but the positions we take on morality and decency, and Catholicism’s teaching that all life is sacred and needs to be respected and honored.

As creatures made in the image and likeness of God, humans need to understand that our laws, customs and mores need to reflect this truth on every level.

MPDN is anti-religion when that religion promotes theologically grounded teachings like the sacredness of life from its first beginnings to its natural end, and the sanctity of traditional marriage between one man and one woman.

As such, MPDN sets up a straw-man argument, lying about Church Militant so it may demonize the work the religious outfit does. Church Militant is proudly pro-woman, pro-life and pro-immigrant.

For further information, call (248) 545-5716.

###

 

Have a news tip? Submit news to our tip line.

Like our work? Support us with a donation.

Here’s That Press Release Summerhill Sent About Its Bullet Hole Wall, in Full

Posted by on 3:57 am in Press Release | 0 comments

SUMMER OASIS SUMMERHILL OPENS IN CROWN HEIGHTS
Reformed Corporate Tax Attorney Turns Vacant Bodega into Surf Club-Style ‘Boozy Sandwich Shop’

CROWN HEIGHTS – An oasis has appeared on Nostrand Avenue just in time for the stickiest, sweatiest days of New York summer.

Summerhill is Crown Heights’ most Instagrammable, “let’s just crush some watermelon cocktails” hangout. With a boardwalk vibe and a killer cross-breeze, it’s easy to forget you’re sitting across the street from a Key Food and not the Rockaway break.

Helmed by Toronto transplant Becca Brennan, Summerhill serves up a high-low beer menu from Tecate to Evil Twin, rosé on tap, and bright cocktails with made-in-house purees, syrups, and herbal touches like celery shrub (featured in the #Vanlife), fresh watermelon juice and ginger syrup (in the Answer), torched rosemary (in the Dated Old Fashioned), and strawberry-basil puree (in the Summer Jam).

Summerhill’s food menu focuses on lovingly prepared, refreshingly unpretentious sandwiches like the Chicken Fried (hot chicken, buttermilk ranch, slaw and pickles) and the perfect BLT (applewood-smoked bacon, bibb lettuce, and beefsteak tomato, heightened by a garlic aioli), plus substantial vegetarian options (Brennan is a lifelong vegetarian) such as the Keep Austin Weird (panko-fried avocado, honey, jalapeno-pickled radish arugula, and red pepper aioli).

Brennan was a corporate tax attorney with daydreams of opening a boozy sandwich shop until she discovered the perfect piece of real estate around the corner from her Crown Heights apartment: a long-vacant corner bodega (with a rumored backroom illegal gun shop to boot). Brennan signed the lease, gave notice and proceeded to spend over a year painstakingly gut-renovating the space with an uncompromising vision: a surf club vibe with a large concrete horseshoe bar, massive accordion windows, and cheekily wallpapered bathrooms. (Yes, that bullet hole-ridden wall was originally there and, yes, we’re keeping it.)

The vision, says Brennan, was “to open a place that I could imagine working from all day; that feeling goes for our staff and our customers.”

Summerhill has quickly become a favorite among locals as a day-drinking magnet on sweltering summerafternoons. Come winter, Summerhill will provide a similar escape from the chill.

Cyclocross Race & Series Promoter Press Release Services – 2017/2018

Posted by on 1:36 am in Press Release | 0 comments

Each season race promoters reach out to us to inquire about how to target our audience and get the word out about their events. To this end, we have a race and series promoter offering that assembles several promotional options into a discounted package. See our 2017/2018 season’s options below.

Cyclocross Magazine has the focused audience eager to know more about your cyclocross series. Over the past few years, numerous races and series have partnered with us to help fill their start lines and make them major successes. Based on this experience, we’ve custom tailored several marketing packages specifically for cyclocross race promoters like yourself. These are limited time promotional opportunities designed to maximize awareness of and attendance at your race.

Notes:

  • Banner ads are 300×250, and can be geo-targeted to the area of your choice.
  • Press releases are published on our website, and pushed out through Facebook and Twitter as well. We’ll publish the post-season recap whether or not you choose a package, just send us the info.
  • The featured story simply means your event press release will be inserted into our slider and gets higher visibility outside the bottom right Press Releases section of our site.

Cyclocross season is coming at us fast and our takeover and contest calendar is filling up, so we can only offer these packages for a limited time. Preferred timeframes will be available on a first-come, first-served basis, so get on board soon to lock down your ideal schedule. The packages above can be customized to suit your needs, please contact us ASAP and we’ll build your perfect promotional platform!

To discuss any of the above options, contact:
Frank Shoemaker
[email protected]
(916) 900-CXM9

Press release: Two Charged Following Police High-speed Chase

Posted by on 1:36 am in Press Release | 0 comments

The two people who were taken into custody immediately following last Wednesday’s incident, where the police were involved in two high-speed chases are now charged. Stacey Barthley, 34 and 26yr-old Saliem Harrigan, Aka “Chucky” both of Green Bay were jointly charged on Saturday with Unlawful Possession of one 9mm and one .22 round of ammunition. Barthley was further charged with Perverting the Course of Justice by Making a False Statement.

Last Wednesday, the police and members of Antigua and Barbuda Defence Force were on mobile patrol, when they spotted a white Toyota Mark-X motor car A46268, travelling on Bendals Road at a high speed, with the occupants inside acting suspiciously. This led to a high-speed chase which ended on Bendals Road, after the driver lost control of the vehicle and crashed it into a wall, and the occupants fled the area on foot. Following that incident, the police were again involved in another high-speed chase with the driver of a beige Toyota Corolla motor car A41256. The driver of that vehicle was signaled by the police to stop, but he refused and drove through the police cordon. The chase ended in Nut Grove, after he lost control of the vehicle and crashed into a fence and also escaped.



Both Harrigan and Barthley were taken into custody as suspects in the matter and questioned. A Search Warrant was executed on their Grays Farm home and the police found two rounds of ammunition. Prior to Barthley being arrested, she made a report to the police that she was robbed of her white Toyota Mark-X motor car by two masked gunmen on Marble Hill Main Road, around 8:35pm the said evening. She reported that she left home to go to KFC on Fort Road; however, she ended up on Marble Hill Main Road and was allegedly accosted by two armed bandits, whom she said stole her vehicle and drove away in it. Investigations into her report have proven to be false, and it is believed that her report was concocted to mislead the investigations.

Police are continuing their investigation into this matter and previous reports of robberies, which the police believed to be connected. Anyone with information is asked to contact the Criminal Investigations Department at 462-3913 or 462-3914.  

Stacey Barthley of Grays Farm

Saliem Harrigan of Grays Farm

Press release: Shelby County man, woman arrested for child endangerment after wreck

Posted by on 12:13 am in Press Release | 0 comments

A Lufkin woman, accused of stealing hydrocodone pills from the pharmacy, where she worked, went to court today.  

Apparently Fake Press Release Roils Radius Health Investors

Posted by on 12:13 am in Press Release | 0 comments

Apparently Fake Press Release Roils Radius Health Investors

Radius Health Inc (NASDAQ: RDUS) shareholders might have had a confusing intraday session Friday as shares plunged about 10 percent on no definitive news.

The day got weirder, however, as the end of the week’s trading drew near. Heading into the 3 p.m. hour, shares of Radius Health inexplicably started rebounding — and sharply.

By the close of Friday’s session, shares were down only 0.3 percent.

As the price action unfolded, Benzinga began digging for some justification.

Around 2:58 p.m. EDT, traders began circulating an apparent GlobeNewswire press release coming from the company. The press release dated July 21, 2017, described, in some arguably rocky language, the fact that Radius would be holding a conference call on the same date to discuss “an unexpected loss.”

Benzinga wasn’t the only source to notice some strange elements of the release, as a handful of investors took to social and voiced their opinion that something fishy might be going on.

Aside from some clear grammar errors, Benzinga was able to confirm, upon dialing the number for the conference line, the event listed in the “press release” was already held on May 24.

Additionally, Radius Health’s corporate website doesn’t include any mention of this conference call. Upon calling Radius Health’s main line, a receptionist answered and said she hadn’t heard about any conference happening on Friday.

Another important item to note with this story and this stock: shortsqueeze.com shows Radius Health’s current short interest around 20 percent, a relatively high level of short interest.

Posted-In: News Legal Exclusives Movers Trading Ideas Best of Benzinga

PR: Announcement of Po.et’s Token Sale August 8, 2017 – Bitcoin …

Posted by on 8:24 pm in Press Release | 0 comments

This is a paid press release, which contains forward looking statements, and should be treated as advertising or promotional material. Bitcoin.com does not endorse nor support this product/service. Bitcoin.com is not responsible for or liable for any content, accuracy or quality within the press release.

Establishing the Ownership and Licensing of the World’s Creative Digital Assets

Po.et, a new protocol designed to accelerate solutions for the digital media industry utilizing blockchain technology and timestamped metadata to create proper attribution and licensing opportunities for publishers have announced their invitation-only POE token sale for August 8, 2017.

The core objectives of Po.et are to create a platform which simplifies the process for publishing, licensing and authentication of digital assets. Simplifying the publishing process necessitates solving the issues of document integrity, licensing, arbitrage, analytics, syndication and attribution of digital assets. Po.et aims to create a Bitcoin blockchain-based platform with added smart contract functionality and applications to facilitate distribution of digital creative works and remove marketplace friction for publishers, editors and content creators by solving these issues, as well as creating greater cost efficiencies in hashing metadata than previously introduced.

Po.et’s platform includes a digital media licensing marketplace and it’s core product – the immutable portfolio, an asset wallet for all creative digital assets where territory and search parameters are considered for licensing and monetization. Po.et is ultimately laying the foundation for an open, blockchain-based protocol for decentralized media applications.
The Po.et native token (POE) serves several purposes: To bootstrap the network effects of Po.et by creating a community of engaged, invested stakeholders and publishers. To raise funds for the long-term development of Po.et and to provide a mechanism to economically reward early adopters and positive contributors to the Po.et network.

“There is a foundational race right now to solve key vertical challenges for the publishing industry. Po.et is born out of a pain we felt deeply at Bitcoin Magazine and we have partnerships identified to work in tandem to create solutions through the Po.et protocol – attribution and licensing marketplaces,” said David Bailey, CEO of BTC Media.

Po.et has previously raised $1 million USD in a pre-sale of tokens from media veterans, institutional investors, and blockchain entrepreneurs. Now Po.et is aiming to raise an additional $9 million USD through the sale of the POE token, which represent a share of revenue generated from commercial activities on the Po.et network.

Of the 3,141,592,653 POE tokens released, 50 percent will be distributed to the community. Of the remaining POE tokens, 10 percent will be distributed to the early investors who funded Po.et development prior to the token sale. An additional 10 percent will be distributed over time to publishers, journalists, alpha publishing partners and others who contribute to growing the Po.et network. The Po.et Foundation will retain 22 percent of all POE tokens for long-term development, with the remaining 8 percent going to the early team and founders.

ABOUT PO.ET:
Po.et – Proof of Existence 2.0 is a Bitcoin blockchain protocol that establishes an open, universal and immutable ledger for managing the unalterable ownership, attribution and licensing of creative digital assets. Po.et builds a bridge between creators and publishers and enables the discovery of new content and verification, authenticity and authorization of generated content through a truly transparent and timestamped system of attribution. Po.et is based in Singapore and the United States, with offices in Los Angeles, CA. For more information about Po.et, please visit po.et.

For further info and the official Po.et whitepaper, visit their website at http://po.et.
For media inquiries or to schedule an interview, contact Jill Richmond or call (973) 710. 6073.


This is a paid press release. Readers should do their own due diligence before taking any actions related to the promoted company or any of its affiliates or services. Bitcoin.com is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in the press release.

Press Release:Two in Custody After High-speed Chase

Posted by on 8:24 pm in Press Release | 0 comments

STRATCOM-A man and woman are now in police custody, following two separate  high-speed chases with the police, resulting in two separate traffic collisions.

It is reported that around 9:40 pm on Wednesday, the police and members of the Antigua and Barbuda Defence Forceb(ABDF) were on mobile patrol, when they came across a White Toyota Mark-X motor car A46268, travelling at a fast speed along Bendals Road with the occupants inside acting suspicious.

An immediate pursuit took place by the police and the vehicle collided into a concrete wall on Bendals Road, after the driver apparently lost control of the vehicle.

The occupants of the car fled the scene on foot. Items were recovered from the vehicle and seized by the police.

In a separate, but what is believed to be a related incident, a beige Toyota Corolla motor car A41256 was spotted by lawmen moments after the first incident in Cashew Hill, with a male driver inside also acting suspicious.

The police signaled him to stop, but he refused and sped away from the area. A high-speed chase ensued, which ended up in Nut Grove, after he lost control of the vehicle and collided into a fence.

He managed to escape from the area on foot. Following both incidents, a Gray’s Farm man and his girlfriend were arrested and taken into custody, and are now assisting the police further with their investigations.

Both vehicles are impounded at Police Headquarters.

PR: Player Lands $64818 in Just One Spin on Hansel & Gretel at BitStarz Casino

Posted by on 7:21 pm in Press Release | 0 comments

This is a paid press release, which contains forward looking statements, and should be treated as advertising or promotional material. Bitcoin.com does not endorse nor support this product/service. Bitcoin.com is not responsible for or liable for any content, accuracy or quality within the press release.

A legendary $64,818 win landed by a BitStarz player while playing the popular movie themed slot Hansel Gretel: Witch Hunters!

The story of Hansel Gretel by the Brothers Grimm is probably one of the most famous fairy tales of all time. We’re just gonna assume you’ve heard about it, if not, you’ve been missing out.

In the popular slot Hansel Gretel: Witch Hunters, the kids are all grown up, ready to pay some witches a visit, together with a big enough weapon arsenal to take on a small nuclear power, yeah, they’re armed to the teeth.

A fearless player from BitStarz decided to join the Witch Hunt and managed to land an incredible $64,818 in just a single spin, not too shabby for just a few minutes of witch hunting. We’ll throw in our stake next time.

This slot from iSoftbet is based on the Hollywood flick with the same name, and in the range of games from iSoftbet you’ll find plenty of other blockbuster titles, such as Platoon, Basic Instinct, Rango, and many more!

Bitstarz.com offers games of several different providers in a hybrid multi-currency environment and is one of the leading bitcoin casinos on the market, always on the front line of releasing new and exciting games. They’re also top-ranked among over a thousand casinos on the world renowned casino review site AskGamblers.

The Marketing Manager of BitStarz, Srdjan Kapor commented,

“Really happy to hear that the games from iSoftbet are paying out again, and the games from this developer are so underrated. An iSoftbet Slot also have the record for biggest payout in BitStarz history, of 150 BTC ($385,000), I recommend any slot player to at least try them out!”.

Press Contact Email Address
srdjan.kapor@bitstarz.com
Supporting Link
Bitstarz.com


This is a paid press release. Readers should do their own due diligence before taking any actions related to the promoted company or any of its affiliates or services. Bitcoin.com is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in the press release.

An Irrational Reaction To TherapeuticsMD’s News Release

Posted by on 7:21 pm in Press Release | 0 comments

I wrote an earlier article on the catalytic event (receiving of FDA minutes) that occurred July 18 for TherapeuticsMD (NYSEMKT:TXMD), and had projected a positive outcome would lead to a 20%-30% increase in share price. As expected, the company issued a press release, but it did not mention anything regarding a resubmission pathway for approval, which I and the market had expected.

The lack of details in the press release led to uncertainty about the path forward for TX-004HR. This was viewed as slightly negative news by the markets, and the stock fell by 6.57%, ending the trading day at $5.26.

In order to find out more about the path ahead for TX-004HR, I spoke with the head of investor relations, David DeLucia. The following are my findings based on the interview.

Reason behind the FDA’s request for a 52-week study

Initially, the company was worried that the need for the long-term safety data was a result of a safety signal from existing estrogen products. However, in the Type A meeting, the FDA confirmed that there were no broader safety issues with the use of low-dose vaginal estrogen products on the market today. They also confirmed that there were no safety issues with TX-004HR in the 12-week Rejoice Trial.

The FDA admitted that the actual reason for requesting a 52-week study was due to an unfortunate oversight in the trial design discussion. They had originally wanted a 52-week study from the start, but made a mistake in failing to communicate this. This is in spite of them acknowledging their own guidance, which was written in 2003: A 12-week study for an estrogen-only product targeting a vulvar and vaginal atrophy (VVA) indication (Source: FDA’s industry guidance for estrogen products to treat VVA).

At present, the company remains unsure why the FDA requested a 52-week trial prior to approval, especially when the company had submitted a 505(NYSE:B)(2) application with the ability to reference all the medical literature regarding the safety of estradiol. With the submission of new information, the company is optimistic that a 52-week study is not required for the path forward.

Details on the ‘new information’ being submitted

The company submitted three pieces of new information to the FDA on July, 5: 1) a study on the first uterine pass effect, 2) an unpublished observational study conducted by the National Institutes of Health (NIH), and 3) a Phase 4 post marketing study proposal.

The first study on first uterine pass effect (Source: “First uterine pass effect” is observed when estradiol is placed in the upper but not lower third of the vagina) demonstrated a lower risk of endometrial hyperplasia when the hormone is applied to the lower third of the vagina. The lower third of the vagina is exactly where TX-004HR will be applied, thus reinforcing its safety profile.

The second study is an unpublished observational study conducted by the NIH. This study enrolled over 90,000 women and studied these women over an average period of 8 years to understand the long-term effect of hormone therapy use. While this study will only be published in the next 4 to 6 weeks, the authors of the publication had kindly submitted the unpublished data to the FDA on the company’s behalf. The company had not seen the data, but according to the experts involved in the study, there was no evidence of safety signal for years with vaginal estrogen products. Thus, reinforcing once again the strong safety profile of vaginal estrogen based products like TX-004HR.

Lastly, a Phase 4 post marketing study proposal was submitted to reassure the FDA of the safety profile of TX-004HR without the need to conduct a 52-week study. This is a sign of good faith by the company and is theoretically not required when there is no safety signal observed as per FDA’s guidance (Source: FDA’s industry guidance for post-marketing studies).

The additional studies were viewed as new information by the FDA, and they felt these studies could positively impact the NDA for TX-004HR. Thus, the FDA requested some time to review the new information. The company expects the FDA to respond within the next 1 to 2 weeks.

What will happen now?

The FDA is projected to get back to the company within 1 to 2 weeks with updates regarding the path forward for approval. There are a couple of possible scenarios:

Scenario 1

The FDA can potentially approve TX-004HR in light of the new information submitted, since there is no scientific basis to require a 52-week study. This case is strengthened by the large-scale, long-term NIH study. However, the company feels this is an aggressive assumption and unlikely to happen. I expect a short squeeze with strong upward price movement if this scenario plays out.

Scenario 2

The FDA requests the company resubmit a new NDA. This new NDA will include the proposed changes the company mentioned in their presentation: conducting a post-marketing study, dropping of the 25mcg dose, and adopting a black box label. However, in light of the new information submitted, the FDA could request a resubmission without the need for a black box label.

The company expects the resubmission to be categorized as a Class 1 resubmission. The timeline for approval is about 3 months from the date of resubmission. The 3-month timeframe includes a 30-day period for the FDA to issue an acknowledgment letter that they had received the new NDA (Source: FDA’s guidance for resubmission with regards to CRLs) and an additional 2 months to review the NDA for a final decision. So expect an approval date by mid-November.

And mid-November might be a pessimistic outcome, since the crucial change in resubmission will be the post-marketing proposal, which is currently being reviewed by the FDA. As such, the company feels the approval process could be much shorter.

According to the company, the base-case scenario is for a resubmission with the black box label. I expect a modest increase in stock price if this scenario plays out and a more significant price jump if the FDA is willing to drop the black box label.

Scenario 3

The FDA delays their decision regarding the path forward to a much later date in September/October or insists on a 52-week study. The company has stated that, should this occur, they will utilize the dispute resolution pathway.

The FDA consultants hired by the company advised against this pathway, since it has a historical low chance of success (Source: An FDA Analysis of Formal Dispute Resolution in the Center for Drug Evaluation and Research: 2003 Through 2014). However, the company feels they have a strong case for approval through the dispute resolution pathway. Their belief is backed by 1) written correspondence with the FDA throughout the phase 3 trial, which did not mention the need to conduct a 52-week study; 2) admission of a mistake by the FDA recorded in the Type A meeting minutes; and 3) strong safety data of low-dose vaginal hormone therapy.

There is essentially no scientific basis for a 52-week safety study, which will be a waste of resources and contradicts the reason the 505(B)(2) pathway was introduced. With the current political climate advocating eliminating unnecessary studies, the company is confident of a successful approval through the dispute resolution pathway. The company expects a 60- to 90-day timeframe for approval after submission of the appeal. So expect approval by early- to mid-Q4 2017.

Despite the strong case for approval, the markets will most likely view the use of the dispute resolution pathway as a negative due to a historically low success rate. If this scenario plays out, be prepared for the stock price to take a hit. Still, investors should remain positive, as history is not necessarily a good gauge of future outcome. The company has a strong case for an approval without an additional 52-week study.

Scenario 4

The most bearish scenario will be the FDA insisting on a 52-week study with the appeal through the dispute resolution pathway being rejected. The company feels this scenario is unlikely to happen, as the company has a strong scientific backing for approval without the need of a 52-week study.

In this scenario, shorts will be right in their investment thesis. Investors will most likely face dilution to raise capital to conduct the 52-week study. If this scenario plays out, the stock will dive to a new all-time low, possibly even below $3.50. However, I have to emphasize this is a very unlikely outcome.

Dilution possibility

At present, the company is comfortable with its cash balance of $113 million as of Q1 17. The company expects to raise more cash to prepare for the launch of their new products, TX-004HR and TX-001HR. With approval expected by the end of the year, the company has conveyed that a stock dilution will only be done as a last resort. They will be favoring other sources of capital, like ex-US partnerships and debt capital markets, for additional cash.

Conclusion

The shorts are playing on investors’ unfounded fear that TX-004HR will not be approved without a long-term study, thus leading to a dilution in the near term. This is clearly an unlikely outcome, with science on the company’s side to get an approval by the end of the year. Once again, do not let fear and price movement dictate your investment decisions. The investment thesis for the company remains intact.

Disclosure: I am/we are long TXMD.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.